Antimicrobial effect of phytic acid on Enterococcus faecalis

Objective One of the properties of an ideal root canal irrigant is the ability to eradicate Enterococcus faecalis which is one of the most resistant microorganisms encountered in persistent peri-radicular lesions. The aim of this study was to test the in vitro antibacterial effectiveness of a naturally occurring agent called phytic acid (IP6) against E. faecalis and compare it to the antibacterial activities of clinically used irrigants: sodium hypochlorite (NaOCl), ethylenediaminetetraacetic (EDTA), phosphoric acid (PA) and chlorhexidine (CHX). Design The antimicrobial activities of 5% IP6, 5% NaOCl, 18% EDTA, 37% PA and 2% CHX against E. faecalis were determined using disk diffusion test. Minimum inhibitory concentration (MIC) was calculated by broth macrodilution method. The minimal bactericidal concentration (MBC) was determined for the used agents by culturing the clear broth of MIC tests. Results The results of agar diffusion test showed statistically signiï¬cant differences between the groups. PA showed a larger zone when compared to other tested materials (p< 0.05). There was no statistical significant difference between NaOCl, EDTA and CHX (p=0.098). IP6 showed the smallest zone of inhibition when compared to all groups (p< 0.05).The recorded MIC and MBC values for IP6 were 0.156% and 0.625%; respectively. The MIC and MBC values for PA were 0.578% and 4.6% and for NaOCl 0.093% and 0.375%, respectively. EDTA MIC value was 0.14 % but it showed no bactericidal activity. CHX was excluded from MIC test as immediate precipitation and turbidity occurred after mixing CHX with Mueller Hinton Broth. Conclusions Within the limitation of this study and despite that IP6 showed the smallest zone of inhibition in agar diffusion test, the results of MIC and MBC indicated that IP6 exhibits in vitro antibacterial effect against E. faecalis at low concentrations

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Abstract Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Endodontic infections: management of pathogenic biofilms

Endodontic infections are biofilm-associated hence the challenge in eradication of such infections with a high risk of losing the infected tooth. The mainstay of root canal treatment involves mechanical debridement and use of chemical irrigants. However, irrigants currently employed are known to have poor biocompatibility with host cells. In addition, these chemicals may present wider health and environmental risks. Biofilms’ high tolerance to these irrigants means that treatment failure is commonplace. Therefore, there is pressing need for identification of an improved irrigant. Phytic acid (IP6), a natural agent that has been proposed as a potential endodontic irrigant due to its chelating activity. However, its antimicrobial and antibiofilm activity is poorly studied. Therefore, the overarching aim of this research was to investigate antimicrobial characteristics of IP6. This study focused on pathogenic microorganisms associated with endodontic infections and included assessment of organisms from root canals with necrotic dental pulp. IP6 antimicrobial activity was assessed against planktonic cultures and in vitro generated biofilms of infection-associated pathogens. IP6 was antimicrobial against planktonic cultures and biofilms at low concentrations and exhibited bactericidal activity against E. faecalis with a 30 s contact time. IP6 also had antibiofilm effects on mature mono and dual species biofilms. The microbiota of root canals in teeth with necrotic pulp and periapical disease from patients of the Gulf region had high bacterial diversity and contained several antibiotic resistance genes and virulence factors. The in vitro biofilm models generated from these clinical samples on hydroxyapatite (HA) coupons were reproducible and polymicrobial. IP6 exhibited antibiofilm action against these developed biofilms. Importantly, IP6 resulted in substantial inhibition of dual-species (E. faecalis and C. albicans) biofilm formation when used as a pre-conditioning agent for HA coupons. The overall results of this PhD research highlight the antimicrobial properties of IP6 and its potential for exploitation in biofilm inhibition and management

Global variation in postoperative mortality and complications after cancer surgery: a multicentre, prospective cohort study in 82 countries

© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 licenseBackground: 80% of individuals with cancer will require a surgical procedure, yet little comparative data exist on early outcomes in low-income and middle-income countries (LMICs). We compared postoperative outcomes in breast, colorectal, and gastric cancer surgery in hospitals worldwide, focusing on the effect of disease stage and complications on postoperative mortality. Methods: This was a multicentre, international prospective cohort study of consecutive adult patients undergoing surgery for primary breast, colorectal, or gastric cancer requiring a skin incision done under general or neuraxial anaesthesia. The primary outcome was death or major complication within 30 days of surgery. Multilevel logistic regression determined relationships within three-level nested models of patients within hospitals and countries. Hospital-level infrastructure effects were explored with three-way mediation analyses. This study was registered with ClinicalTrials.gov, NCT03471494. Findings: Between April 1, 2018, and Jan 31, 2019, we enrolled 15 958 patients from 428 hospitals in 82 countries (high income 9106 patients, 31 countries; upper-middle income 2721 patients, 23 countries; or lower-middle income 4131 patients, 28 countries). Patients in LMICs presented with more advanced disease compared with patients in high-income countries. 30-day mortality was higher for gastric cancer in low-income or lower-middle-income countries (adjusted odds ratio 3·72, 95% CI 1·70–8·16) and for colorectal cancer in low-income or lower-middle-income countries (4·59, 2·39–8·80) and upper-middle-income countries (2·06, 1·11–3·83). No difference in 30-day mortality was seen in breast cancer. The proportion of patients who died after a major complication was greatest in low-income or lower-middle-income countries (6·15, 3·26–11·59) and upper-middle-income countries (3·89, 2·08–7·29). Postoperative death after complications was partly explained by patient factors (60%) and partly by hospital or country (40%). The absence of consistently available postoperative care facilities was associated with seven to 10 more deaths per 100 major complications in LMICs. Cancer stage alone explained little of the early variation in mortality or postoperative complications. Interpretation: Higher levels of mortality after cancer surgery in LMICs was not fully explained by later presentation of disease. The capacity to rescue patients from surgical complications is a tangible opportunity for meaningful intervention. Early death after cancer surgery might be reduced by policies focusing on strengthening perioperative care systems to detect and intervene in common complications. Funding: National Institute for Health Research Global Health Research Unit

Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study

© 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 licenseBackground: Early death after cancer surgery is higher in low-income and middle-income countries (LMICs) compared with in high-income countries, yet the impact of facility characteristics on early postoperative outcomes is unknown. The aim of this study was to examine the association between hospital infrastructure, resource availability, and processes on early outcomes after cancer surgery worldwide. Methods: A multimethods analysis was performed as part of the GlobalSurg 3 study—a multicentre, international, prospective cohort study of patients who had surgery for breast, colorectal, or gastric cancer. The primary outcomes were 30-day mortality and 30-day major complication rates. Potentially beneficial hospital facilities were identified by variable selection to select those associated with 30-day mortality. Adjusted outcomes were determined using generalised estimating equations to account for patient characteristics and country-income group, with population stratification by hospital. Findings: Between April 1, 2018, and April 23, 2019, facility-level data were collected for 9685 patients across 238 hospitals in 66 countries (91 hospitals in 20 high-income countries; 57 hospitals in 19 upper-middle-income countries; and 90 hospitals in 27 low-income to lower-middle-income countries). The availability of five hospital facilities was inversely associated with mortality: ultrasound, CT scanner, critical care unit, opioid analgesia, and oncologist. After adjustment for case-mix and country income group, hospitals with three or fewer of these facilities (62 hospitals, 1294 patients) had higher mortality compared with those with four or five (adjusted odds ratio [OR] 3·85 [95% CI 2·58–5·75]; p<0·0001), with excess mortality predominantly explained by a limited capacity to rescue following the development of major complications (63·0% vs 82·7%; OR 0·35 [0·23–0·53]; p<0·0001). Across LMICs, improvements in hospital facilities would prevent one to three deaths for every 100 patients undergoing surgery for cancer. Interpretation: Hospitals with higher levels of infrastructure and resources have better outcomes after cancer surgery, independent of country income. Without urgent strengthening of hospital infrastructure and resources, the reductions in cancer-associated mortality associated with improved access will not be realised. Funding: National Institute for Health and Care Research